| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/06/2004 | US20040086974 Comprises human tumor suppressor protein for treatment and prevention of cell proliferative disorders; antitumor/anticarcinogenic/antiproliferative agents |
| 05/06/2004 | US20040086952 Monoclonal antibody comrpising affininty for 5-lipoxygenase activating polypeptide (FLAP) for diagnosis, prevention and treatment of inflamation, asthma and glomerulonephritis; gastric cytoprotective agents |
| 05/06/2004 | US20040086942 Comprises peptide mimetic which competes for binding site of immunoglobulin receptor and prevents and treats allergic disorders |
| 05/06/2004 | US20040086940 Novel g protein-coupled receptor protein and dna thereof |
| 05/06/2004 | US20040086923 Comprises polypeptide with carbamoyl phosphate synthase (CPS) activity for identifying modulators which prevent and/or treat cancer and metabolic disorders |
| 05/06/2004 | US20040086899 Compromises nuclelotide sequences coding polypeptides associated with elongation of fatty acid chains for treatment and prevention of skin, cardiovascular, inflammatory, gastrointestinal, respiratory system and bone disorders |
| 05/06/2004 | US20040086863 Comprises pleckstrin homology domain-interacting protein (PHI Protein) for identifying modulator and treatment for cancer and insulin response disorders |
| 05/06/2004 | US20040086585 Composition and methods for treating Alzheimer's disease and other amyloidoses |
| 05/06/2004 | US20040086561 For preventing oral abuse of an oral opioid formulation |
| 05/06/2004 | US20040086540 Topically administering to an area on the subject where ectoparasites are present a composition comprising a fatty acid ester and at least 20% cyclic siloxane |
| 05/06/2004 | US20040086514 Based on the finding of a specific Helicobacter pylori receptor in the human gastric epithelium; a glycolipid, lactotetraosylceramide, exclusively found in the human gastrointestinal tract |
| 05/06/2004 | US20040086498 Cancer therapy |
| 05/06/2004 | US20040086492 Achieves a remarkable improvement in the effect of the treatment of a tumor such as cancer by administering activated lymphocytes over a specific period of time before or after the implementation of photodynamic therapy |
| 05/06/2004 | US20040086487 Prevention or the treatment of congestive heart failure or myocardial ishchemia by administering a sphingosine kinase, or an analogue, fragment, or derivative thereof |
| 05/06/2004 | EP1416048A1 Nucleic acid participating in the formation of presenilin-2-gene exon 5-;defective splicing variant |
| 05/06/2004 | EP1415997A1 Polypeptides relating to signal transfer of advanced glycation end product receptor |
| 05/06/2004 | EP1415994A1 Retinal pigmented epithelium derived neurotrophic factor |
| 05/06/2004 | EP1415987A1 Nitrogenous aromatic ring compounds |
| 05/06/2004 | EP1415986A1 Spiro compounds |
| 05/06/2004 | EP1415983A1 5-amidino-n-(2-aminophenethyl)-hydroxybenzenesulfonamide derivative, medicinal composition containing the same, and intermediate therefor |
| 05/06/2004 | EP1415982A1 Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors |
| 05/06/2004 | EP1415668A1 Remedies for brain ischemic diseases |
| 05/06/2004 | EP1415667A1 Pancreatic juice secretion regulators comprising lpa receptor controller |
| 05/06/2004 | EP1415663A1 Sustained release hgf hydrogel preparations |
| 05/06/2004 | EP1415661A1 Homing of embryonic stem cells to a target zone in tissue for delivery of translocation stimulators |
| 05/06/2004 | EP1415659A1 BAFF, inhibitors thereof and their use in the modulation of the B-cell response |
| 05/06/2004 | EP1415658A1 Remedies |
| 05/06/2004 | EP1415657A1 Remedies |
| 05/06/2004 | EP1415655A1 Immunotherapy for humans |
| 05/06/2004 | EP1415653A2 Use of progesterone or an agonist thereof for the inhibition of steroid synthesis |
| 05/06/2004 | EP1415651A1 Preventives/remedies for cholinergic neuropathy |
| 05/06/2004 | EP1415650A1 Nutritional composition for the prevention and treatment of cachexia and anorexia |
| 05/06/2004 | EP1415154A2 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors |
| 05/06/2004 | EP1414967A2 Gene associated with leishmania parasite virulence |
| 05/06/2004 | EP1414965A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/06/2004 | EP1414964A2 Vegf isoform |
| 05/06/2004 | EP1414963A2 Lipid-associated molecules |
| 05/06/2004 | EP1414948A2 Inhibition of apoptosis process and improvement of cell performance |
| 05/06/2004 | EP1414947A2 Multipotent stem cells from peripheral tissues and uses thereof |
| 05/06/2004 | EP1414846A2 Molecule |
| 05/06/2004 | EP1414837A1 Adenosine a3 receptor agonists |
| 05/06/2004 | EP1414826A1 Therapeutically useful tetracyclic ligands |
| 05/06/2004 | EP1414825A1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 05/06/2004 | EP1414819A1 THERAPEUTIC 1H-PYRIDO 4,3-b]INDOLES |
| 05/06/2004 | EP1414812A1 Hydroxamic acid derivatives |
| 05/06/2004 | EP1414810A2 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 05/06/2004 | EP1414809A1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 05/06/2004 | EP1414808A1 1,2,4-triazin-3,5-diones as gonadotropin-releasing hormone receptor (gnrh) antagonists |
| 05/06/2004 | EP1414807A1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 05/06/2004 | EP1414806A1 Novel vinyl n-(2-benzoylphenyl)-l-tyrosine derivatives and their use as antidiabetics etc |
| 05/06/2004 | EP1414805A1 Indazole or indole derivatives, their use in human medicine and more particularly in cancerology |
| 05/06/2004 | EP1414804A1 Acylsemicarbazides and their use as cyclin dependent kinase (cdk) inhibitors |
| 05/06/2004 | EP1414802A1 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 05/06/2004 | EP1414801A1 Arylamines for the treatment of conditions associated with gsk-3 |
| 05/06/2004 | EP1414797A2 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
| 05/06/2004 | EP1414790A1 Substituted n-acyl aniline derivatives, production and use thereof as medicaments |
| 05/06/2004 | EP1414788A1 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists |
| 05/06/2004 | EP1414778A1 Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. |
| 05/06/2004 | EP1414775A2 Novel bicyclic and tricyclic cannabinoids |
| 05/06/2004 | EP1414526A2 Antiangiogenic combination therapy for the treatment of cancer |
| 05/06/2004 | EP1414525A2 2-(3,5-bis-trifluoromethyl-phenyl)-n-[6-(1,1-dioxo-1.lambda.6-thiomorpholin-4-yl)-4-(2-methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-n-methyl-isobutyramide |
| 05/06/2004 | EP1414522A2 Carbonic anhydrase inhibitors |
| 05/06/2004 | EP1414498A2 Stabilized formulations of interferons with sulfoalkyl ether cyclodextrins |
| 05/06/2004 | EP1414494A1 Inhibitors of her3 activity |
| 05/06/2004 | EP1414491A2 Methods of inhibiting amyloid toxicity |
| 05/06/2004 | EP1414481A2 Use of lhrh-antagonists for the improvement of t-cell mediated immunity |
| 05/06/2004 | EP1414480A1 Osteogenic growth oligopeptides as stimulants of hematopoiesis |
| 05/06/2004 | EP1414475A2 An herbal composition for the treatment and remedy of bronchial respiratory difficulties |
| 05/06/2004 | EP1414471A2 Therapeutic agents comprising pro-apoptotic proteins |
| 05/06/2004 | EP1414470A1 Micronutrient phosphates as dietary and health supplements |
| 05/06/2004 | EP1414469A2 Formulation containing (lyso-) phosphatidylserine for the prevention and treatment of stress states in warm-blooded animals |
| 05/06/2004 | EP1414466A1 Combinations for the treatment of inflammatory disorders |
| 05/06/2004 | EP1414460A1 Process for the preparation of 2-(2-(4-(bis(4-fluorophenyl)methyl)-piperazin-1-yl)ethoxy)acetic acid derivatives or corresponding salt forms thereof and intermediates therefor |
| 05/06/2004 | EP1414457A1 Chiral dinapsoline |
| 05/06/2004 | EP1414455A1 Isoquinoline inhibitors of p38 |
| 05/06/2004 | EP1414451A1 Opioid agonist formulations with releasable and sequestered antagonist |
| 05/06/2004 | EP1414450A1 (pyridinyl and pyrimidyl)trienoic acid derivatives as retinoid x receptor modulators |
| 05/06/2004 | EP1414447A1 Use of thiazole derivatives for preparing a medicine for protecting mitochondria |
| 05/06/2004 | EP1414444A1 Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
| 05/06/2004 | EP1414443A1 BENZIMIDAZO 4,5-f]ISOQUINOLINONE DERIVATIVES |
| 05/06/2004 | EP1414442A1 3-arylsulfonyl-7-piperazinyl- indoles, -benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders |
| 05/06/2004 | EP1414441A2 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 05/06/2004 | EP1414439A1 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 05/06/2004 | EP1414438A1 Antineoplastic combinations |
| 05/06/2004 | EP1414435A1 Crystalline composition containing escitalopram |
| 05/06/2004 | EP1414428A1 Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
| 05/06/2004 | EP1414409A1 Stabilized oral suspension formulation |
| 05/06/2004 | EP1414408A1 Composition comprising paroxetine and a pharmaceutically acceptable glycyrrhizinate salt |
| 05/06/2004 | EP1414405A1 Invert emulsion containing dhea |
| 05/06/2004 | EP1414401A1 Utilization of creatinine and/or creatinine derivatives in cosmetic and dermatological preparations |
| 05/06/2004 | EP1414390A1 Nanocapsules containing a steroid for cosmetic compositions |
| 05/06/2004 | EP1305307B1 Indole derivatives useful for the treatment of cns disorders |
| 05/06/2004 | EP1280802B1 Indazoles substituted with 1,1-dioxoisothiazolidine useful as inhibitors of cell proliferation |
| 05/06/2004 | EP1268407B1 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 05/06/2004 | EP1263753B1 Imidazol derivatives as raf kinase inhibitors |
| 05/06/2004 | EP1261602B1 Imidazol-2-carboxamide derivatives as raf kinase inhibitors |
| 05/06/2004 | EP1261600B1 Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2 |
| 05/06/2004 | EP1257548B1 Benzofuran carboxamides and their therapeutic use |
| 05/06/2004 | EP1227714B1 Method for producing metabolites from plants cultivated in soil-less medium |
| 05/06/2004 | EP1226438B1 Composite nanospheres and their conjugates with biomolecules |